Users Online: 739

Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 
     

    Article Cited by others

ORIGINAL ARTICLE

Beta-interferon therapy in relapsing and remitting multiple sclerosis - challenges in an emerging country

Radhakrishnan Sureshkumar, Padmajan Rajeswary Kalathil, Yadav Praveen Kumar, James Emmanuel, Anandkumar Anandakuttan

Year : 2014| Volume: 4| Issue : 5 | Page no: 34-38

   This article has been cited by
 
1 Substrate Specific Inhibitor Designed against the Immunomodulator GMF-beta Reversed the Experimental Autoimmune Encephalomyelitis
Jane Jose Vattathara,Ohm Prakash,Sunitha Subhramanian,Madathiparambil Kumaran Satheeshkumar,Tessy Xavier,Meenakshi Anil,Gopal S. Pillai,Anandkumar Anandakuttan,Sureshkumar Radhakrishnan,T. B. Sivanarayanan,Unni AKK,Chethampadi Gopi Mohan,Krishnakumar N. Menon
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
2 Significance of elevated Prohibitin 1 levels in Multiple Sclerosis patients lymphocytes towards the assessment of subclinical disease activity and its role in the central nervous system pathology of disease
Madathiparambil Kumaran Satheesh Kumar,Sreepriya Nair,Ullas Mony,Sugavanan Kalingavarman,Ramaswamynathan Venkat,Thanghalazhi Balakrishnan Sivanarayanan,Ayalur Kodakara Kochugovindan Unni,Ramiah Rajeshkannan,Anandakumar Anandakuttan,Sureshkumar Radhakrishnan,Krishnakumar N. Menon
International Journal of Biological Macromolecules. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article